Marcel Wacker

1.5k total citations
9 papers, 107 citations indexed

About

Marcel Wacker is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Marcel Wacker has authored 9 papers receiving a total of 107 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Marcel Wacker's work include vaccines and immunoinformatics approaches (5 papers), Peptidase Inhibition and Analysis (4 papers) and Immunotherapy and Immune Responses (3 papers). Marcel Wacker is often cited by papers focused on vaccines and immunoinformatics approaches (5 papers), Peptidase Inhibition and Analysis (4 papers) and Immunotherapy and Immune Responses (3 papers). Marcel Wacker collaborates with scholars based in Germany, Belgium and Portugal. Marcel Wacker's co-authors include Annika Nelde, Juliane S. Walz, Hans‐Georg Rammensee, Jens Bauer, Tatjana Bilich, Andreas Peter, Helmut R. Salih, Yacine Maringer, Sebastian Hörber and Jonas S. Heitmann and has published in prestigious journals such as Cancer Research, Genome biology and Science Translational Medicine.

In The Last Decade

Marcel Wacker

6 papers receiving 105 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcel Wacker Germany 3 90 32 27 25 10 9 107
Jonas Rieth Germany 3 90 1.0× 31 1.0× 30 1.1× 25 1.0× 14 1.4× 5 108
Ana Jimena Pavlovitch-Bedzyk United States 2 76 0.8× 36 1.1× 39 1.4× 9 0.4× 8 0.8× 3 98
Pinja Jalkanen Finland 6 58 0.6× 13 0.4× 24 0.9× 12 0.5× 5 0.5× 12 83
Fanny Onodi France 5 60 0.7× 39 1.2× 65 2.4× 21 0.8× 17 1.7× 5 124
Victoria Murray United States 6 129 1.4× 41 1.3× 50 1.9× 32 1.3× 10 1.0× 8 171
Sujana Sivapatham Switzerland 4 110 1.2× 35 1.1× 58 2.1× 51 2.0× 14 1.4× 6 157
Francis Swaneveld Netherlands 4 123 1.4× 12 0.4× 24 0.9× 46 1.8× 7 0.7× 7 134
Krystallenia Paniskaki Germany 5 108 1.2× 14 0.4× 30 1.1× 51 2.0× 9 0.9× 11 140
Josipa Jerak Switzerland 2 80 0.9× 28 0.9× 32 1.2× 11 0.4× 5 0.5× 3 88
Tatjana Bilich Germany 6 100 1.1× 58 1.8× 56 2.1× 28 1.1× 33 3.3× 10 153

Countries citing papers authored by Marcel Wacker

Since Specialization
Citations

This map shows the geographic impact of Marcel Wacker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel Wacker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel Wacker more than expected).

Fields of papers citing papers by Marcel Wacker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcel Wacker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel Wacker. The network helps show where Marcel Wacker may publish in the future.

Co-authorship network of co-authors of Marcel Wacker

This figure shows the co-authorship network connecting the top 25 collaborators of Marcel Wacker. A scholar is included among the top collaborators of Marcel Wacker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcel Wacker. Marcel Wacker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Dubbelaar, Marissa L., Petra Zimmermann, Jens Bauer, et al.. (2025). PCI-DB: a novel primary tissue immunopeptidome database to guide next-generation peptide-based immunotherapy development. Journal for ImmunoTherapy of Cancer. 13(4). e011366–e011366. 4 indexed citations
2.
Sachsenberg, Timo, Ralf Gabriels, Jens Bauer, et al.. (2025). MHCquant2 refines immunopeptidomics tumor antigen discovery. Genome biology. 26(1). 290–290.
3.
4.
Jung, Susanne, Jonas S. Heitmann, Yacine Maringer, et al.. (2024). iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimens. Frontiers in Oncology. 14. 1441625–1441625.
5.
Wacker, Marcel, Jens Bauer, Marissa L. Dubbelaar, et al.. (2023). Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics. Frontiers in Immunology. 14. 1219720–1219720. 6 indexed citations
7.
Schroeder, Sarah M., Annika Nelde, Marcel Wacker, et al.. (2022). Abstract 3555: Immunopeptidomics-guided tumor antigen warehouse design for peptide-based immunotherapy in head and neck squamous cell carcinomas. Cancer Research. 82(12_Supplement). 3555–3555. 1 indexed citations
8.
Bilich, Tatjana, Annika Nelde, Jonas S. Heitmann, et al.. (2021). T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals. Science Translational Medicine. 13(590). 92 indexed citations
9.
Bilich, Tatjana, Annika Nelde, Jonas S. Heitmann, et al.. (2020). Differential Kinetics of T Cell and Antibody Responses Delineate Dominant T Cell Epitopes in Long-Term Immunity after COVID-19. SSRN Electronic Journal. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026